BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 28238244)

  • 1. NT-ProBNP as a Potential Marker of Left Atrial Dysfunction in Rheumatic Mitral Stenosis: Correlation with Left Atrial Function after PBMV.
    Khare R; Dwivedi S
    J Heart Valve Dis; 2016 Sep; 25(5):613-618. PubMed ID: 28238244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation.
    Shang YP; Lai L; Chen J; Zhang F; Wang X
    J Heart Valve Dis; 2005 Jul; 14(4):453-9. PubMed ID: 16116870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of percutaneous balloon mitral valvuloplasty on N-terminal- pro B- type natriuretic peptide plasma levels in mitral stenosis.
    Selcuk MT; Selcuk H; Maden O; Erbay AR; Temizhan A; Aksu T; Saydam GS; Korkmaz S
    Int Heart J; 2007 Sep; 48(5):579-90. PubMed ID: 17998767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous left atrial echo contrast, mitral annular systolic velocity, and left atrial appendage late emptying velocity in predicting improvement of left atrial function after percutaneous balloon mitral valvuloplasty.
    Arava TN; Durgaprasad R; Velam V; Gajjala OR; Neelam VK; Manohar SN
    Echocardiography; 2018 Feb; 35(2):162-169. PubMed ID: 29178504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT dispersion in patients with rheumatic mitral stenosis and its relation with echocardiographic findings and serum NT-proBNP levels.
    Kılıçkesmez KO; Bulut G; Başkurt M; Coşkun U; Yıldız A; Küçükoğlu S
    Turk Kardiyol Dern Ars; 2011 Apr; 39(3):183-90. PubMed ID: 21532293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of percutaneous mitral balloon valvuloplasty on left atrial appendage function: transesophageal echo study.
    Ganeswara Reddy V; Rajasekhar D; Vanajakshamma V
    Indian Heart J; 2012; 64(5):462-8. PubMed ID: 23102383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of percutaneous balloon mitral valvuloplasty in patients of rheumatic heart disease mitral stenosis combined with tricuspid regurgitation.
    Chen ZQ; Hong L; Wang H; Lu LX; Yin QL; Lai HL; Li HT; Wang X
    Chin Med J (Engl); 2015 Jun; 128(11):1479-82. PubMed ID: 26021504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal proBNP plasma levels correlate with severity of mitral stenosis.
    Iltumur K; Karabulut A; Yokus B; Yavuzkir M; Taskesen T; Toprak N
    J Heart Valve Dis; 2005 Nov; 14(6):735-41. PubMed ID: 16359052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the Global Echo-Doppler Score (GEDS) in selection of patients with mitral stenosis for percutaneous balloon mitral valvuloplasty.
    Mahfouz RA; Dewedar A; Elzayat A; Elawady W
    Cardiol J; 2014; 21(2):152-7. PubMed ID: 23799559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial asynchrony and mechanical function in patients with mitral stenosis before and immediately after percutaneous balloon mitral valvuloplasty: a real time three-dimensional echocardiography study.
    Deng Y; Guo SL; Su HY; Wang Q; Tan Z; Wu J; Zhang D
    Echocardiography; 2015 Feb; 32(2):291-301. PubMed ID: 24930760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between plasma proadrenomedullin level and severity of the disease in patients with isolated rheumatic mitral stenosis.
    Demir AR; Çetin İ; Kalkan AK; Avcı Y; Altunova M; Uygur B; Yılmaz E; Ertürk M
    Turk Kardiyol Dern Ars; 2021 Oct; 49(7):522-532. PubMed ID: 34623294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous balloon mitral valvuloplasty for mitral stenosis with and without associated aortic regurgitation.
    Chen CR; Cheng TO; Chen JY; Zhou YL; Mei J; Ma TZ
    Am Heart J; 1993 Jan; 125(1):128-37. PubMed ID: 8417508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and immediate outcomes of patients who underwent percutaneous balloon mitral valvuloplasty at the Jakaya Kikwete Cardiac Institute, Tanzania.
    Mutagaywa RK; Cramer MJ; Chillo P; Barongo A; Kifai E; Chamuleau S; Eze-Nliam C; Vera NB; Nkya D; Loth A; Alencherry B; Mongella S; Mayala H; Kisenge P; Mwinchete S; Joseph AB; Kwesigabo G; Kamuhabwa A; Albaghdadi M; Ghobrial J; Janabi M
    Cardiovasc J Afr; 2024 Jan-Apr 23; 35(1):16-26. PubMed ID: 36745007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation to NT-ProBNP and remodeling after cardiac surgery.
    Boer BP; Vieira ML; Sampaio RO; Abensur H; Oliveira AG; Fernandes JR; Grinberg M
    Arq Bras Cardiol; 2013 May; 100(5):469-75. PubMed ID: 23579620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostication of valvular aortic stenosis using tissue Doppler echocardiography: underappreciated importance of late diastolic mitral annular velocity.
    Poh KK; Chan MY; Yang H; Yong QW; Chan YH; Ling LH
    J Am Soc Echocardiogr; 2008 May; 21(5):475-81. PubMed ID: 17928192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of percutaneous mitral balloon valvuloplasty on left atrial appendage function: a Doppler tissue study.
    Karakaya O; Turkmen M; Bitigen A; Saglam M; Barutcu I; Esen AM; Bulut M; Turkyilmaz E; Kirma C
    J Am Soc Echocardiogr; 2006 Apr; 19(4):434-7. PubMed ID: 16581483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of percutaneous mitral balloon valvuloplasty on left ventricular systolic function via strain and strain rate in patients with isolated rheumatic mitral stenosis.
    Bektaş O; Günaydin ZY; Karagöz A; Vural A; Kaya A; Atmaca H; Sahin O
    J Heart Valve Dis; 2015 Mar; 24(2):204-9. PubMed ID: 26204686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial structural and functional remodeling following balloon mitral valvuloplasty.
    Samaan AA; Hassan A; Hassan M; Said K; El Aroussy W; Fawzy ME; Yacoub M
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):999-1007. PubMed ID: 33211239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous estimation of NT-proBNP on top to mitral flow Doppler echocardiography as an accurate strategy to diagnose diastolic dysfunction in HFNEF.
    Kasner M; Gaub R; Westermann D; Kaplan H; Akpulat S; Steendijk P; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2011 May; 149(1):23-9. PubMed ID: 20053469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.